Adults with obesity who underwent Roux-en-Y gastric bypass achieved a greater excess BMI loss at 10 years compared with those ...

ReShape Lifesciences® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 2 ...